Biochemical studies on lipopolysaccharides of Salmonella R mutants. 4. Phosphate groups linked to heptose units and their absence in some R lipopolysaccharides.

PubWeight™: 1.35‹?› | Rank: Top 10%

🔗 View Article (PMID 5646146)

Published in Eur J Biochem on March 01, 1968

Authors

W Dröge, E Ruschmann, O Lüderitz, O Westphal

Articles by these authors

A new method for the extraction of R lipopolysaccharides. Eur J Biochem (1969) 22.41

Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae. Bacteriol Rev (1966) 13.42

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med (1992) 5.32

Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur J Biochem (1975) 5.29

The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule. J Exp Med (1973) 4.74

Picogram-sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from Gram-negative bacteria. Biochim Biophys Acta (1972) 4.45

Nature and linkages of the fatty acids present in the lipid-A component of Salmonella lipopolysaccharides. Eur J Biochem (1972) 4.15

Interaction of lipopolysaccharides and lipid A with complement. Eur J Biochem (1971) 4.15

Structural investigations on the 2-keto-3-deoxyoctonate region of lipopolysaccharides. Eur J Biochem (1970) 4.14

Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. Eur J Biochem (1971) 4.01

Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem (1985) 3.76

Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature (1995) 3.59

Structural relationship of Salmonella O and R antigens. Ann N Y Acad Sci (1966) 3.54

Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal). Zentralbl Bakteriol Orig A (1979) 3.08

Biological activities of lipid A complexed with bovine-serum albumin. Eur J Biochem (1972) 3.04

Synthesis and use of O-stearoyl polysaccharides in passive hemagglutination and hemolysis. Eur J Biochem (1967) 2.99

Biochemical studies on lipopolysaccharides of Salmonella R mutants. 6. Investigations on the structure of the lipid A component. Eur J Biochem (1969) 2.93

Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci U S A (1994) 2.62

[Immunochemical studies of K antigens from Escherichia coli. II. K antigen from E. coli 08:K42(A):H-]. Biochem Z (1965) 2.20

The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J Immunol (1999) 2.13

Differential determination of the 3-Deoxy-D-mannooctulosonic acid residues in lipopolysaccharides of Salmonella minnesota rough mutants. Eur J Biochem (1983) 2.12

Tumor necrosis factor mediates endotoxic effects in mice. Infect Immun (1987) 2.10

Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J (1994) 2.05

HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J (1995) 2.01

Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture. Int Arch Allergy Appl Immunol (1975) 1.97

Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. J Biol Chem (1998) 1.92

A new gene cluster rfe concerned with the biosynthesis of Salmonella lipopolysaccharide. J Gen Microbiol (1970) 1.91

Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. Prog Allergy (1983) 1.86

Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol Chem Hoppe Seyler (1989) 1.76

Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol (1994) 1.75

Lipid A: chemical structure and biological activity. J Infect Dis (1973) 1.73

Chemical structure and biological activities of lipid A's from various bacterial families. Naturwissenschaften (1978) 1.69

The chemical structure of lipid A. Demonstration of amide-linked 3-acyloxyacyl residues in Salmonella minnesota Re lipopolysaccharide. Eur J Biochem (1982) 1.67

Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. Oncogene (1999) 1.66

The role of the physical state of lipopolysaccharides in the interaction with complement. High molecular weight as prerequisite for the expression of anti-complementary activity. Eur J Biochem (1976) 1.64

Studies on the structure of lipopolysaccharides of Salmonella minnesota and Salmonella typhimurium R strains. Biochem J (1965) 1.60

Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. Infect Immun (1984) 1.59

Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives. AIDS (1991) 1.57

Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. Scand J Infect Dis Suppl (1982) 1.56

[Investigations on the Typing of salmonella R-forms. IV. Typing of S. minnesota-R-mutants by antibiotics]. Zentralbl Bakteriol Orig (1970) 1.55

Daily subcutaneous administration of human growth hormone in growth hormone deficient children. Acta Paediatr Scand (1986) 1.53

Improvement of immune functions in HIV infection by sulfur supplementation: two randomized trials. J Mol Med (Berl) (2000) 1.50

Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Lancet (1997) 1.49

A lipopolysaccharide-binding cell-surface protein from Salmonella minnesota. Isolation, partial characterization and occurrence in different Enterobacteriaceae. Eur J Biochem (1979) 1.49

[Growth and lipopolysaccharide (O-antigen) levels of salmonella in cultures of agar media]. Zentralbl Bakteriol Orig (1966) 1.49

Metabolic disorder as early consequence of simian immunodeficiency virus infection in rhesus macaques. Lancet (1991) 1.48

A new class of heptose-defective mutant of Salmonella typhimurium. Eur J Biochem (1973) 1.48

IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J (1995) 1.47

Composition of lipopolysaccharides from Myxococcus fulvus and other fruiting and non-fruiting myxobacteria. Eur J Biochem (1974) 1.46

The immunochemistry of Salmonella chemotype VI O-antigens. The structure of oligosaccharides from Salmonella group G (o 13,22) lipopolysaccharides. Biochem J (1965) 1.46

[Antibiotic sensitivity in S- and R-forms of Salmonella minnesota]. Naturwissenschaften (1968) 1.45

Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin. Infect Immun (1973) 1.38

Biological activities of chemically modified endotoxins. Eur J Biochem (1971) 1.36

Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog Clin Biol Res (1987) 1.35

Recent results on the biochemistry of the cell wall lipopolysaccharides of Salmonella bacteria. Angew Chem Int Ed Engl (1970) 1.35

The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. Eur J Biochem (2000) 1.34

Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur J Biochem (1984) 1.33

Occurrence of 3-amino-3,6-dideoxyhexoses in Salmonella and related bacteria. J Bacteriol (1967) 1.30

Relations between structures of three K polysaccharides of Escherichia coli and cross-reactivity in antipneumococcal sera. J Bacteriol (1968) 1.30

Immunological priming without production of circulating bacterial antibodies conditioned by endotoxin and its lipoid A component. Nature (1966) 1.28

Interactions of the complement system with endotoxins from a Salmonella minnesota mutant deficient in O-polysaccharide and heptose. J Immunol (1968) 1.27

[Polysaccharides of vegetative and aggregationally competent amoebae of the strain Dictyostelium discoideum. 1. In vivo degradation of bacterial lipopolysaccharides]. Eur J Biochem (1967) 1.27

Biochemical studies on lipopolysaccharides of Salmonella R mutants. 3. The linkage of the heptose units. Eur J Biochem (1968) 1.25

[Investigations on the classification of salmonella R forms. 3. Classification of S. minnesota mutants by chemical agents]. Zentralbl Bakteriol Orig (1969) 1.25

Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut (1998) 1.24

Structural investigations on the core polysaccharide of Escherichia coli 0100. Eur J Biochem (1971) 1.24

Structural studies on the heptose region of Salmonella lipopolysaccharides. Eur J Biochem (1973) 1.23

Lipopolysaccharides: structural principles and biologic activities. Rev Infect Dis (1984) 1.22

The occurrence of 4-amino-4-deoxy-L-arabinose as a constituent in Salmonella lipopolysaccharide preparations. Eur J Biochem (1970) 1.20

Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab (1996) 1.20